Hema Madhusudan

Hema Madhusudan

Active Director Director DIN 07223891
DIN 07223891 First appointment Jun 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Hema Madhusudan

Data last updated:

Hema Madhusudan is a Director at Capsinta Life Sciences Private Limited (since 2015). The company operates in Chemicals. Capsinta Life Sciences Private Limited reported revenue of ₹88.6 Lakh (FY 2024).

DIN 07223891
Primary Designation Director
Industry Chemicals
First Appointment 29 Jun 2015
Oldest Company Age 12 yrs
Largest company Capsinta Life Sciences Private Limited · ₹88.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jun 20152014₹88.6 Lakh (FY 2024)Active

Board colleagues of Hema Madhusudan

Directorship timeline

Open interactive timeline →
Capsinta Life Sciences Private Limited
Premium access

Shareholding and investment profile for Hema Madhusudan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Madhusudan

Hema Madhusudan currently holds 1 directorship: Capsinta Life Sciences Private Limited (Director, since 29 Jun 2015, revenue ₹88.6 Lakh (FY 2024)).

Hema Madhusudan was first appointed on 29 Jun 2015 as Director at Capsinta Life Sciences Private Limited.

The current boards of Hema Madhusudan's companies include Madaiah Madhusuddan Beeraiah (Capsinta Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available